Title : Serum paraoxonase levels in pancreatic cancer - Akcay_2003_Hepatogastroenterology_50 Suppl 2_ccxxv |
Author(s) : Akcay MN , Polat MF , Yilmaz I , Akcay G |
Ref : Hepato-Gastroenterology , 50 Suppl 2 :ccxxv , 2003 |
Abstract :
BACKGROUND/AIMS: Serum paraoxonase (PON) is a calcium-dependent esterase that is known to contribute to the antioxidant protection conferred by high-density lipoprotein (HDL) on low-density lipoprotein (LDL) oxidation. Serum PON activity was shown to be reduced in patients with diseases such as myocardial infarction, diabetes mellitus, etc in comparison to healthy subjects. However, the relation of serum PON levels to cancer is still not known. So, we intended to measure serum PON, HDL, LDL and very low-density lipoprotein (VLDL) levels and to investigate the relation of serum PON to plasma lipoproteins in the patients with pancreatic cancer. METHODOLOGY: We measured serum PON, HDL, LDL, and VLDL levels in 20 patients with pancreatic cancer and in 20 age-and gender-matched healthy controls. We investigated the relationship between PON and HDL, PON and LDL, and PON and VLDL. |
PubMedSearch : Akcay_2003_Hepatogastroenterology_50 Suppl 2_ccxxv |
PubMedID: 15244186 |
Akcay MN, Polat MF, Yilmaz I, Akcay G (2003)
Serum paraoxonase levels in pancreatic cancer
Hepato-Gastroenterology
50 Suppl 2 :ccxxv
Akcay MN, Polat MF, Yilmaz I, Akcay G (2003)
Hepato-Gastroenterology
50 Suppl 2 :ccxxv